Cross NC - Search Results

1

KIT D816V and JAK2 V617F mutations are seen recurrently in hypereosinophilia of unknown significance.

Schwaab J, Umbach R, Metzgeroth G, Naumann N, Jawhar M, Sotlar K, Horny HP, Gaiser T, Hofmann WK, Schnittger S, Cross NC, Fabarius A, Reiter A. Schwaab J, et al. Among authors: cross nc. Am J Hematol. 2015 Sep;90(9):774-7. doi: 10.1002/ajh.24075. Epub 2015 Aug 14. Am J Hematol. 2015. PMID: 26017288 Free article.

2

Quantitative molecular methods to monitor the response of CML patients to interferon-alpha.

Hochhaus A, Lin F, Reiter A, Skladny H, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: cross nc. Bone Marrow Transplant. 1996 May;17 Suppl 3:S41-4. Bone Marrow Transplant. 1996. PMID: 8769700

3

Molecular response of CML patients treated with interferon-alpha monitored by quantitative Southern blot analysis. German chronic myeloid leukaemia (CML) Study Group.

Reiter A, Skladny H, Hochhaus A, Seifarth W, Heimpel H, Bartram CR, Cross NC, Hehlmann R. Reiter A, et al. Among authors: cross nc. Br J Haematol. 1997 Apr;97(1):86-93. doi: 10.1046/j.1365-2141.1997.32645.x. Br J Haematol. 1997. PMID: 9136945 Free article.

4

Monitoring the efficiency of interferon-alpha therapy in chronic myelogenous leukemia (CML) patients by competitive polymerase chain reaction.

Hochhaus A, Lin F, Reiter A, Skladny H, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: cross nc. Leukemia. 1997 Apr;11 Suppl 3:541-4. Leukemia. 1997. PMID: 9209451

5

The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome.

Kulkarni S, Reiter A, Smedley D, Goldman JM, Cross NC. Kulkarni S, et al. Among authors: cross nc. Genomics. 1999 Jan 1;55(1):118-21. doi: 10.1006/geno.1998.5634. Genomics. 1999. PMID: 9889006

6

The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.

Macdonald D, Reiter A, Cross NC. Macdonald D, et al. Among authors: cross nc. Acta Haematol. 2002;107(2):101-7. doi: 10.1159/000046639. Acta Haematol. 2002. PMID: 11919391 Review.

7

The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.

Baxter EJ, Hochhaus A, Bolufer P, Reiter A, Fernandez JM, Senent L, Cervera J, Moscardo F, Sanz MA, Cross NC. Baxter EJ, et al. Among authors: cross nc. Hum Mol Genet. 2002 Jun 1;11(12):1391-7. doi: 10.1093/hmg/11.12.1391. Hum Mol Genet. 2002. PMID: 12023981

8

Tyrosine kinase fusion genes in chronic myeloproliferative diseases.

Cross NC, Reiter A. Cross NC, et al. Leukemia. 2002 Jul;16(7):1207-12. doi: 10.1038/sj.leu.2402556. Leukemia. 2002. PMID: 12094244 Review.

9

The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.

Reiter A, Walz C, Watmore A, Schoch C, Blau I, Schlegelberger B, Berger U, Telford N, Aruliah S, Yin JA, Vanstraelen D, Barker HF, Taylor PC, O'Driscoll A, Benedetti F, Rudolph C, Kolb HJ, Hochhaus A, Hehlmann R, Chase A, Cross NC. Reiter A, et al. Among authors: cross nc. Cancer Res. 2005 Apr 1;65(7):2662-7. doi: 10.1158/0008-5472.CAN-04-4263. Cancer Res. 2005. PMID: 15805263 Free article.

10

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.

Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, White H, Zoi C, Loukopoulos D, Terpos E, Vervessou EC, Schultheis B, Emig M, Ernst T, Lengfelder E, Hehlmann R, Hochhaus A, Oscier D, Silver RT, Reiter A, Cross NC. Jones AV, et al. Among authors: cross nc. Blood. 2005 Sep 15;106(6):2162-8. doi: 10.1182/blood-2005-03-1320. Epub 2005 May 26. Blood. 2005. PMID: 15920007 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

413 results

Search Page